MedTrace Logo

A Real-world Study on the Treatment of Adult B-cell Acute Lymphoblastic Leukemia With CNCT-19

NCT07269587 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 275

Last updated 2025-12-10

No results posted yet for this study

Summary

This clinical study is a retrospective, observational, and multicenter post marketing real-world study aimed at evaluating the efficacy and safety of CNCT-19 in the treatment of Chinese adult B-cell acute lymphoblastic leukemia patients.

Conditions

  • ALL (Acute B-Lymphoblastic Leukemia)
  • CAR-T Cell Therapy

Interventions

DRUG

CNCT-19

All patients have received CNCT-19

Sponsors & Collaborators

  • Ruijin Hospital

    lead OTHER

Eligibility

Min Age
14 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-11-07
Primary Completion
2027-11-30
Completion
2027-11-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07269587 on ClinicalTrials.gov